Comparative Pharmacology
Head-to-head clinical analysis: BENTYL PRESERVATIVE FREE versus DUAKLIR PRESSAIR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BENTYL PRESERVATIVE FREE versus DUAKLIR PRESSAIR.
BENTYL PRESERVATIVE FREE vs DUAKLIR PRESSAIR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dicyclomine is a muscarinic acetylcholine receptor antagonist (anticholinergic) that inhibits the action of acetylcholine on structures innervated by postganglionic parasympathetic nerves. It reduces smooth muscle spasm in the gastrointestinal tract by blocking M1, M2, and M3 receptors, with a predominant effect on M3 receptors in the gut.
Dual bronchodilator combining a long-acting muscarinic antagonist (aclidinium) and a long-acting beta2-agonist (formoterol). Aclidinium inhibits acetylcholine at M3 receptors, reducing bronchoconstriction; formoterol stimulates beta2-adrenergic receptors, relaxing airway smooth muscle.
20 mg orally three times daily; may increase to 40 mg three times daily if tolerated.
1 inhalation (aclidinium 400 mcg / formoterol 12 mcg) twice daily.
None Documented
None Documented
Terminal elimination half-life: 1.9–3.3 hours (in healthy adults). Clinically, short half-life necessitates frequent dosing for sustained effect.
Terminal half-life 5.0–6.5 hours (aclidinium); steady-state reached within 2 days; no accumulation at therapeutic doses
Renal: ~50% (mostly as metabolites), Biliary/Fecal: ~40% (as unchanged drug and metabolites), minor via enterohepatic circulation.
Renal (55% as unchanged aclidinium; 20% as metabolites); biliary/fecal (33% as metabolites and parent)
Category C
Category C
Anticholinergic
Anticholinergic/Beta2-Agonist Combination